Rohto Pharmaceutical Co., Ltd. (UC1)
Market Closed
14 Aug, 20:00
XDUS XDUS Primary €
15. 00
-0.2
-1.3158%
€
- Market Cap
- P/E Ratio
0.27% Div Yield
0 Volume
- Eps
€ 15.2
Previous Close Want to track UC1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rohto Pharmaceutical Co., Ltd. (UC1) Statistics
Valuation metrics
Market Cap -
Enterprise value -26.94B
Trailing P/E (ttm) 0.09
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 225.96M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 19
Average volume (90 days) 6
Price summary
52-Week low 11.9
52-Week high 15.2
Beta -
50-Day moving average 12.61
200-Day moving average 13.49
Dividends and splits
Forward annual dividend rate 0.27
Forward annual dividend yield 0.0201%
Trailing annual dividend rate 0.25
Trailing annual dividend yield 0.0185%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 7 Apr 2026
Ex-Dividend Date 30 Mar 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -
Return on equity -
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 145.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 47.08B
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 2.17%
Book value per share (mrq) 1,293.42
Cash Flow
Cash flow statement 36.82B
Levered free cash flow (LFCF) -
